Showing 1 - 20 results of 98 for search 'Meletios A. Dimopoulos', query time: 0.05s Refine Results
  1. 1
    Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis

    Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis by Foteini Theodorakakou, Meletios A. Dimopoulos, Efstathios Kastritis

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?

    Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning? by Anastasios Kyriazoglou, Flora Zagouri, Meletios A Dimopoulos

    Published 2019-06-01
    Get full text
    Article
  3. 3
    Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies

    Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies by Nikos G. Gavalas, Meletios A. Dimopoulos, Aristotelis Bamias

    Published 2011-12-01
    Get full text
    Article
  4. 4
    Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma

    Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma by Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos

    Published 2022-05-01
    Get full text
    Article
  5. 5
    Future Developments in the Treatment of AL Amyloidosis

    Future Developments in the Treatment of AL Amyloidosis by Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos, Efstathios Kastritis

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Current and novel BTK inhibitors in Waldenström’s macroglobulinemia

    Current and novel BTK inhibitors in Waldenström’s macroglobulinemia by Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou, Meletios A. Dimopoulos

    Published 2021-02-01
    Get full text
    Article
  7. 7
    The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma

    The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma by Maria Gkotzamanidou, Evangelos Terpos, Meletios A. Dimopoulos, Vassilis L. Souliotis

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Metabolic Disorders in Multiple Myeloma

    Metabolic Disorders in Multiple Myeloma by Maria Gavriatopoulou, Stavroula A. Paschou, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos

    Published 2021-10-01
    Get full text
    Article
  9. 9
    <i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges

    <i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges by Tina Bagratuni, Alexandra Papadimou, Kostantina Taouxi, Meletios A. Dimopoulos, Efstathios Kastritis

    Published 2023-09-01
    Get full text
    Article
  10. 10
    The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer

    The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer by Alexandros Drivalos, Athanasios G. Papatsoris, Michael Chrisofos, Eleni Efstathiou, Meletios A. Dimopoulos

    Published 2011-06-01
    Get full text
    Article
  11. 11
    SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

    SARS-CoV-2 Vaccines in Patients With Multiple Myeloma by Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, Evangelos Terpos, Meletios A. Dimopoulos

    Published 2021-03-01
    Get full text
    Article
  12. 12
    What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature

    What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature by Anna Svarna, Michalis Liontos, Georgios Reppas, Oraianthi Fiste, Angeliki Andrikopoulou, Meletios A. Dimopoulos, Flora Zagouri

    Published 2023-02-01
    Get full text
    Article
  13. 13
    Leukocytoclastic Vasculitis after Long-Term Treatment with Sunitinib: A Case Report

    Leukocytoclastic Vasculitis after Long-Term Treatment with Sunitinib: A Case Report by Alexandra Karadimou, Magdalini Migou, Afroditi Economidi, Alexandros Stratigos, Christos Kittas, Meletios A. Dimopoulos, Aristotle Bamias

    Published 2011-08-01
    Get full text
    Article
  14. 14
    The Emerging Role of Convalescent Plasma in the Treatment of COVID-19

    The Emerging Role of Convalescent Plasma in the Treatment of COVID-19 by Theodora Psaltopoulou, Theodoros N. Sergentanis, Vasiliki Pappa, Marianna Politou, Evangelos Terpos, Sotirios Tsiodras, George N. Pavlakis, Meletios A. Dimopoulos

    Published 2020-06-01
    Get full text
    Article
  15. 15
    Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma

    Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma by Konstantinos Papadimitriou, Ioannis V. Kostopoulos, Anastasia Tsopanidou, Nikolaos Orologas-Stavrou, Efstathios Kastritis, Ourania E. Tsitsilonis, Meletios A. Dimopoulos, Evangelos Terpos

    Published 2020-07-01
    Get full text
    Article
  16. 16
    Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response

    Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response by Ioanna Dagla, Aikaterini Iliou, Dimitra Benaki, Evagelos Gikas, Emmanuel Mikros, Tina Bagratuni, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Terpos, Anthony Tsarbopoulos

    Published 2022-04-01
    Get full text
    Article
  17. 17
    Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses

    Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses by Rebecca Georgakopoulou, Oraianthi Fiste, Theodoros N. Sergentanis, Angeliki Andrikopoulou, Flora Zagouri, Maria Gavriatopoulou, Theodora Psaltopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos

    Published 2021-09-01
    Get full text
    Article
  18. 18
    Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

    Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications by Ioannis P. Trougakos, Kimon Stamatelopoulos, Evangelos Terpos, Ourania E. Tsitsilonis, Evmorfia Aivalioti, Dimitrios Paraskevis, Efstathios Kastritis, George N. Pavlakis, Meletios A. Dimopoulos

    Published 2021-01-01
    Get full text
    Article
  19. 19
    An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment

    An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment by Meletios A. Dimopoulos, Joseph Mikhael, Evangelos Terpos, Xavier Leleu, Philippe Moreau, Joan Bladé, Jin Seok Kim, Keith Stockerl-Goldstein, Paul G. Richardson

    Published 2022-04-01
    Get full text
    Article
  20. 20
    Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

    Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals by Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Aimilia D. Sklirou, Maria Gavriatopoulou, Harry Alexopoulos, Panagiotis Malandrakis, Ioannis P. Trougakos, Meletios A. Dimopoulos, Evangelos Terpos

    Published 2022-07-01
    Get full text
    Article

Search Tools: